Wire Stories

Ifinatamab Deruxtecan Continues to Demonstrate Durable Responses in Patients with Advanced Small Cell Lung Cancer in Early Trial

Encouraging objective response rate of 52.4% was seen with ifinatamab deruxtecan in heavily pretreated patients…

Datopotamab Deruxtecan Plus Durvalumab Showed Promising Clinical Activity in the First-Line Advanced Non-Small Cell Lung Cancer Setting in TROPION-Lung04 Phase 1b Trial

Daiichi Sankyo and AstraZeneca’s datopotamab deruxtecan plus durvalumab with or without chemotherapy demonstrated objective response…

TVBS 30th Anniversary Interactive Exhibition – Taiwan broadcaster aims to become a leading global and local media hubÂ

  TAIPEI,Taiwan--(BUSINESS WIRE)--TVBS, the Taiwanese broadcasting network that kicked off operations in 1993, marks its…

AM Best Downgrades Credit Ratings of Thaire Life Assurance Public Company Limited

SINGAPORE--(BUSINESS WIRE)--#insurance--AM Best has downgraded the Financial Strength Rating to B++ (Good) from A- (Excellent)…

Princess Polly Lands in Los Angeles With First U.S. Store at Westfield Century City

The Australian-born brand beloved by Gen Z makes its U.S. debut SAN FRANCISCO--(BUSINESS WIRE)--a.k.a. Brands…

Ant Group Unveils its Financial Large Language Model and Two New Applications

Financial LLM is in closed test with financial institution partners on Ant Group’s wealth management…

Gift of China: Zhuyeqing Tea Celebrates 10th Anniversary of the New Silk Road

PARIS--(BUSINESS WIRE)--Zhuyeqing Tea is regarded as the gift of China in the New Silk Road…

Ant Group Digital Technologies Launches ZAN to Provide Blockchain Application Development Products and Services to Web3 Community

HONG KONG--(BUSINESS WIRE)--At this year’s INCLUSION · Conference on the Bund, Ant Group Digital Technologies…

Newmont Announces Date of Special Meeting of Stockholders and Filing of Definitive Proxy Statement for Acquisition of Newcrest

Federal Court of Australia Orders Convening of Scheme Meeting and Dispatch of Scheme Booklet DENVER--(BUSINESS…